CHICAGO – Under a law now in effect from state Rep. Camille Y. Lilly, D-Chicago, out-of-pocket costs to patients for a one-month supply of lifesaving insulin are capped at $100 per month.
“No person or family should have to choose between lifesaving medication and a roof over their head or food on the table,” Lilly said. “This law to cap insulin costs for patients is about putting the well-being of Illinoisans ahead of the profits of drug companies.”
Lilly co-sponsored a law, Public Act 101-0625, to cap insulin costs for patients at $100 per 30-day supply. The law, which went into effect on Jan. 1, 2021, seeks to address a massive spike in insulin prices over the past two decades. According to the American Diabetes Association (ADA), the list price of insulin has nearly tripled since 2002 and has risen at an even higher rate of 64% since 2014. Capping insulin costs for Illinoisans in need is part of Lilly’s broader effort to improve health care access and affordability for every person in Illinois.
“I believe that equitable access to health care is a human right and that building a stronger Illinois means lowering health care costs for patients,” Lilly said. “Profiteering drug companies should take notice that Illinois will ensure that their days of profits ahead of people are coming to an end.”
Visit Rep Lilly’s website
200-8S Stratton Office Building
Springfield, IL 62706
(217) 558-1054 FAX
6937 W. North Ave.
Oak Park, IL 60302